Advertisement
Singapore markets closed
  • Straits Times Index

    3,265.95
    +1.42 (+0.04%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • Dow

    39,056.39
    +172.13 (+0.44%)
     
  • Nasdaq

    16,302.76
    -29.80 (-0.18%)
     
  • Bitcoin USD

    61,348.12
    -978.75 (-1.57%)
     
  • CMC Crypto 200

    1,320.95
    +20.85 (+1.60%)
     
  • FTSE 100

    8,376.90
    +22.85 (+0.27%)
     
  • Gold

    2,324.60
    +2.30 (+0.10%)
     
  • Crude Oil

    79.48
    +0.49 (+0.62%)
     
  • 10-Yr Bond

    4.4920
    0.0000 (0.00%)
     
  • Nikkei

    38,073.98
    -128.39 (-0.34%)
     
  • Hang Seng

    18,537.81
    +223.95 (+1.22%)
     
  • FTSE Bursa Malaysia

    1,601.22
    -3.53 (-0.22%)
     
  • Jakarta Composite Index

    7,088.79
    -34.82 (-0.49%)
     
  • PSE Index

    6,542.46
    -116.72 (-1.75%)
     

Zoetis' (NYSE:ZTS) 9.6% CAGR outpaced the company's earnings growth over the same five-year period

It hasn't been the best quarter for Zoetis Inc. (NYSE:ZTS) shareholders, since the share price has fallen 17% in that time. But the silver lining is the stock is up over five years. Unfortunately its return of 53% is below the market return of 84%.

After a strong gain in the past week, it's worth seeing if longer term returns have been driven by improving fundamentals.

See our latest analysis for Zoetis

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

ADVERTISEMENT

Over half a decade, Zoetis managed to grow its earnings per share at 12% a year. The EPS growth is more impressive than the yearly share price gain of 9% over the same period. So it seems the market isn't so enthusiastic about the stock these days.

The image below shows how EPS has tracked over time (if you click on the image you can see greater detail).

earnings-per-share-growth
earnings-per-share-growth

We know that Zoetis has improved its bottom line lately, but is it going to grow revenue? This free report showing analyst revenue forecasts should help you figure out if the EPS growth can be sustained.

What About Dividends?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for Zoetis the TSR over the last 5 years was 58%, which is better than the share price return mentioned above. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

Investors in Zoetis had a tough year, with a total loss of 9.0% (including dividends), against a market gain of about 24%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. On the bright side, long term shareholders have made money, with a gain of 10% per year over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering. It's always interesting to track share price performance over the longer term. But to understand Zoetis better, we need to consider many other factors. Take risks, for example - Zoetis has 1 warning sign we think you should be aware of.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.